Enovis Co. (NYSE:ENOV) Receives $71.44 Average PT from Brokerages

Shares of Enovis Co. (NYSE:ENOV) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $71.44.

A number of brokerages recently weighed in on ENOV. Needham & Company LLC reiterated a “buy” rating and set a $82.00 price objective on shares of Enovis in a report on Friday, May 3rd. Evercore ISI dropped their price objective on Enovis from $70.00 to $62.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Finally, JPMorgan Chase & Co. began coverage on Enovis in a report on Thursday, June 13th. They set a “neutral” rating and a $53.00 price objective on the stock.

Institutional Trading of Enovis

A number of hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC increased its holdings in shares of Enovis by 19.9% in the 1st quarter. GAMMA Investing LLC now owns 1,085 shares of the company’s stock valued at $68,000 after acquiring an additional 180 shares during the period. Treasurer of the State of North Carolina grew its stake in Enovis by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 23,252 shares of the company’s stock valued at $1,303,000 after purchasing an additional 220 shares during the last quarter. Retirement Systems of Alabama grew its stake in Enovis by 0.4% in the fourth quarter. Retirement Systems of Alabama now owns 62,222 shares of the company’s stock valued at $3,486,000 after purchasing an additional 251 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in Enovis by 5.4% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 5,185 shares of the company’s stock worth $290,000 after purchasing an additional 264 shares in the last quarter. Finally, Louisiana State Employees Retirement System lifted its position in shares of Enovis by 2.1% during the first quarter. Louisiana State Employees Retirement System now owns 14,300 shares of the company’s stock valued at $893,000 after buying an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 98.45% of the company’s stock.

Enovis Stock Down 1.9 %

Shares of NYSE ENOV opened at $45.80 on Thursday. The company has a market cap of $2.51 billion, a P/E ratio of -30.53 and a beta of 1.92. The firm has a 50-day simple moving average of $46.98 and a two-hundred day simple moving average of $54.59. Enovis has a 1 year low of $43.04 and a 1 year high of $65.88. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.10 and a quick ratio of 1.03.

Enovis (NYSE:ENOV) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.50 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.50. Enovis had a positive return on equity of 3.98% and a negative net margin of 4.51%. The company had revenue of $516.00 million during the quarter, compared to analysts’ expectations of $505.62 million. During the same quarter in the previous year, the business earned $0.44 EPS. Enovis’s revenue was up 27.0% compared to the same quarter last year. Research analysts anticipate that Enovis will post 2.62 earnings per share for the current year.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.